The treatment of ocular hypotony after trabeculectomy with a scleral lens: A case series

Elving-Kokke, Karolien; Sas-Meertens, M. A. V.; Beer, Florian; Rijn, L.J. van; Boer, Joke H. de; Visser, Esther-Simone

doi:10.1016/j.clae.2018.10.018

Cited by 6 publications

(1 citation statement)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The success of trabeculectomy is not only on the surgery itself but more importantly on the frequent follow-up visits for post-operative medication and "bleb" management (Olali, Rotchford, & King, 2011;Singh et al, 2007;Elving-Kokke et al, 2019). In addition to the anti-scarring medications, there are other methods that are sometimes used after the surgery for controlling fluid pressure or enhancing aqueous humor filtration into the bleb via the ostium created, such as eye massage (Mead et al, 2003;Wang et al, 2022;Georgoulas et al, 2008;Lama & Fechtner, 2003;Razeghinejad, Fudemberg, & Spaeth, 2012).…”

Section: Introductionmentioning

confidence: 99%

The Outcomes of Trabeculectomy Surgery among Patients at Makkah Specialist Eye Hospital Bauchi Nigeria

Oluwasegun¹,

Abdalla²,

Madaki³

et al. 2023

IJRP

View full text Add to dashboard Cite

Trabeculectomy remains the world's gold standard and the main therapeutic intervention for controlling moderate to advanced glaucoma in Nigeria due to the expensive anti-glaucoma drugs as well as the unavailability of facilities to carry out minimal invasive glaucoma surgery (MIGS). There is still limited knowledge of the outcomes of trabeculectomy surgery in northeastern, Nigeria. To determine the outcomes of trabeculectomy surgery, regarding lowering post-operative Intra Ocular Pressure (IOP), preserved visual acuity (VA) as well as preserved functional vision among glaucoma patients attending Makkah Specialist Eye Hospital Bauchi (MSEHB). A retrospective trabeculectomy surgery data search of operating theatre records was done to collect the outcomes from January 2021 to January 2023. Patients who have undergone trabeculectomy with a minimum follow-up of 6 months were included in the study. The criteria for a good outcome were post-operative IOP of less than 22mmHG or at least 30% reduction from pre-operative levels, and a preserved aided VA. A visiting consultant from the Ophthalmology Department of Federal Teaching Hospital Gombe performed the trabeculectomy surgeries. A total of fifty-two eyes of 50 patients having a postoperative follow-up of six months were included in the study. The mean age at presentation was 54.10(± 13.02) years. On the last day before surgery, the mean Snellen VA was 20/60; 0.37(± 0.36) but became 20/60+3; 0.40(± 0.36) post-operatively, p = 0.01, mean cup-to-disc ratio (CDR) was 0.86(± 0.12) but changed to 0.87(± 0.12) p = 0.79 at six months after surgery. Complete success, qualified success (with postoperative anti-glaucoma eyedrops), and failure of trabeculectomy (even with postoperative anti-glaucoma eyedrops) were 47(90.40%), 4(7.70%), and 1(1.90%), respectively. Based on the IOP, the complete success rate of trabeculectomy was 90.40%. The mean preoperative Snellen VA was improved by about half a line, six months after surgery and there was a significant reduction of IOP from its baseline. These outcomes revolutionize referral/advice of moderate to advanced glaucoma patients for trabeculectomy surgery in our practice as well as assured post-operative reserved vision.

show abstract